DJIA 16,461.32 -153.49 -0.92%
NASDAQ 4,382.85 -36.63 -0.83%
S&P 500 1,927.11 -14.17 -0.73%
market minute promo

Johnson & Johnson (NYSE: JNJ)

101.22 0.86 (0.86%)

REAL-TIME: Last trade at

Extended Hours: $101.22 $0.00 (0.00%)
Quote as of (NYSE)

company name or ticker

Recent Quotes

JNJ $101.22 0.86%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $101.10
Previous Close $100.36
Daily Range $100.52 - $101.79
52-Week Range $86.09 - $108.77
Market Cap $285.5B
P/E Ratio 19.19
Dividend (Yield) $2.80 (2.8%)
Ex-Dividend Date
Dividend Pay Date
Volume 9,360,174
Average Daily Volume 8,757,894
Current FY EPS $5.96





Johnson & Johnson (JNJ) Description

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices. Website:

News & Commentary

Is Johnson & Johnson's Worst Nightmare Becoming Reality?

Johnson & Johnson has become a growth story on the back of strong pharmaceutical sales over the past two quarters. This trend looks like it is about to change with the approval of a rival's game-changing drug.

Worried? Picks Of Mr. Cautious, 80% In Stocks

Pharmacyclics Up on Label Expansion Efforts for Imbruvica - Analyst Blog

Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Leads The Day Higher, Goldman Sachs Group (GS) Lags

Dividend Aristocrats In Focus Part 24: Consolidated Edison

Dividend Aristocrats In Focus Part 24: Consolidated Edison

The Income Buffer In Relation To Price Declines

Ebola-nation travelers to U.S. to be watched 21 days

3 Drugs Stocks Pushing The Industry Higher

Noteworthy ETF Inflows: IVV, AAPL, MSFT, JNJ

Celgene Corporation's Earnings Preview: Pay Attention to New Kids

Revlimid might be the flagship, but growth will come from the newer drugs.

See More JNJ News...

JNJ's Top Competitors

JNJ $101.22 (0.86%)
Current stock: JNJ
PFE $28.30 (0.07%)
Current stock: PFE
MRK $55.51 (0.69%)
Current stock: MRK
BSX $12.32 (2.41%)
Current stock: BSX